| Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy (NCT03791372) | Guangdong Women and Children Hospital | 2017-10-10 |
| Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus (NCT03239470) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-10-10 |
| Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole (NCT03250117) | Titan Pharmaceuticals | 2017-10-10 |
| Molecular Imaging of NET Using [C-11]MRB-PET in MS (NCT03207464) | Brigham and Women's Hospital | 2017-10-10 |
| A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR) (NCT03234712) | AbbVie | 2017-10-10 |
| A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease (NCT04045678) | Luye Pharma Group Ltd. | 2017-10-10 |
| A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors (NCT03129139) | Minneamrita Therapeutics LLC | 2017-10-10 |
| Absorption and Elimination of Radiolabeled Daprodustat (NCT03239522) | GlaxoSmithKline | 2017-10-10 |
| A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy (NCT03270176) | Debiopharm International SA | 2017-10-10 |
| Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine (NCT03300050) | PATH | 2017-10-10 |
| Phase I Trial of 225Ac-J591 in Patients With mCRPC (NCT03276572) | Weill Medical College of Cornell University | 2017-10-10 |
| Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD) (NCT02715505) | Novartis Pharmaceuticals | 2017-10-10 |
| Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders (NCT03292848) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2017-10-10 |
| Feasibility and Acceptability of Implementing a Clinic-based Physical Activity Coaching Intervention in People With Premanifest and Early Stage HD (NCT03306888) | Teachers College, Columbia University | 2017-10-10 |
| A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension (NCT03293992) | Hoffmann-La Roche | 2017-10-10 |
| M7583 Relative Bioavailability of Tablet Compared to Powder-in-capsule (NCT03297983) | Merck KGaA, Darmstadt, Germany | 2017-10-09 |
| A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects. (NCT03388515) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2017-10-09 |
| TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer (NCT03287674) | Inge Marie Svane | 2017-10-09 |
| A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies (NCT03241173) | Incyte Biosciences International Sàrl | 2017-10-09 |
| Phase 1 Study of IM156 in Patients With Advanced Solid Tumor and Lymphoma (NCT03272256) | ImmunoMet Therapeutics, Inc. | 2017-10-09 |
| A First in Human Study to Assess the Safety, Tolerability and Immunogenicity of a Single Dose of a Trivalent Inactivated Poliovirus Vaccine Based on Sabin Strains (sIPV) Given Intramuscularly in Healthy Adults (NCT03032588) | Janssen Vaccines & Prevention B.V. | 2017-10-09 |
| Ga-68-PSMA-11 in High-risk Prostate Cancer (NCT03362359) | German Cancer Research Center | 2017-10-09 |
| Safety, Tolerability, and Pharmacokinetics Study of NDX-1017 (NCT03298672) | LeonaBio | 2017-10-09 |
| FMT in Pediatric Crohn's Disease (NCT03194529) | Children's Hospital Los Angeles | 2017-10-09 |
| An Investigational Study to Assess the Effect of a Light Meal and a High-Fat Meal on the Absorption of BMS-986205 in Healthy Participants (NCT03312426) | Bristol-Myers Squibb | 2017-10-09 |
| Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632) (NCT03168464) | Weill Medical College of Cornell University | 2017-10-09 |
| A Feasibility and Safety Study of Concomitant Therapy With Allo-CAR-T Cells and Allo-HSCT in Patients With Relapse or Refractory Leukemia (NCT03463928) | Chinese PLA General Hospital | 2017-10-08 |
| Safety and Tolerability of Sodium Thiosulfate in Patients With an ACS Undergoing CAG Via Trans-radial Approach. (NCT03017963) | University Medical Center Groningen | 2017-10-06 |
| TVB 2640 for Resectable Colon Cancer Other Resectable Cancers; a Window Trial. (NCT02980029) | Mark Evers | 2017-10-06 |
| Study of SyB C-1101 in Patients With Myelodysplastic Syndrome (NCT03495167) | SymBio Pharmaceuticals | 2017-10-06 |
| A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers (NCT03303911) | Achieve Life Sciences | 2017-10-06 |
| Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma (NCT03349255) | Aeon Therapeutics (Shanghai) Co., Ltd. | 2017-10-06 |
| A Study of KHK4827 in Patients With Systemic Sclerosis (NCT04368403) | Kyowa Kirin Co., Ltd. | 2017-10-06 |
| Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency) (NCT03306667) | Mochida Pharmaceutical Company, Ltd. | 2017-10-06 |
| Phase I/II Clinical Trial of NPF-08 in Healthy Volunteers (NCT03423771) | Nihon Pharmaceutical Co., Ltd | 2017-10-06 |
| Study Investigation Pharmacokinetics and Pharmacodynamics of CS1 (NCT03903302) | Cereno Scientific AB | 2017-10-06 |
| Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women (NCT03408262) | Imperial College London | 2017-10-06 |
| In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM) (NCT02986698) | University of California, San Francisco | 2017-10-05 |
| Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer. (NCT03236974) | AstraZeneca | 2017-10-05 |
| Progesterone and Aminophylline for the Prevention of Preterm Labour (NCT03152942) | St Stephens Aids Trust | 2017-10-05 |
| Brief Stresses Experimental Study (NCT03893617) | Dana Bovbjerg | 2017-10-05 |
| This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated (NCT03165240) | Boehringer Ingelheim | 2017-10-05 |
| VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer (NCT03268057) | Vaccinex Inc. | 2017-10-05 |
| Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma (NCT03319537) | Memorial Sloan Kettering Cancer Center | 2017-10-05 |
| Safety, Tolerability, and Pharmacokinetics of Single Doses of BIIB059 in Healthy Japanese Subjects. (NCT03224793) | Biogen | 2017-10-04 |
| Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma (NCT03189836) | Cogent Biosciences, Inc. | 2017-10-04 |
| Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors (NCT03283202) | Celgene | 2017-10-04 |
| A Study to Evaluate the Irritation Potential of ATx201 in Healthy Volunteers (NCT03301870) | UNION therapeutics | 2017-10-04 |
| Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects. (NCT03520348) | Laboratorios Sophia S.A de C.V. | 2017-10-04 |
| A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma (NCT03215030) | Teva Branded Pharmaceutical Products R&D LLC | 2017-10-04 |
| The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function (NCT03240328) | Guangzhou 8th People's Hospital | 2017-10-04 |
| Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells (NCT03242603) | National University Hospital, Singapore | 2017-10-03 |
| First-in-Human Study of MS201408-0005A as Single Agent and in Combinations (NCT03306420) | EMD Serono Research & Development Institute, Inc. | 2017-10-03 |
| Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma (NCT03229278) | Rutgers, The State University of New Jersey | 2017-10-03 |
| Evaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered Concurrently to Subjects With Various Degrees of Renal Impairment and Healthy Matched Control Subjects (NCT03310463) | Entasis Therapeutics | 2017-10-03 |
| Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors (NCT03261011) | Akesobio Australia Pty Ltd | 2017-10-03 |
| Study to Evaluate the Relative Bioavailability and Safety of the AG-348 Tablet and Capsule Formulations in Healthy Adults (NCT03397329) | Agios Pharmaceuticals, Inc. | 2017-10-03 |
| Autologous Dendritic Cell Vaccination in Mesothelioma (NCT02649829) | University Hospital, Antwerp | 2017-10-03 |
| RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer (NCT03189914) | Processa Pharmaceuticals | 2017-10-02 |
| Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma (NCT03267940) | Halozyme Therapeutics | 2017-10-02 |
| A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients (NCT03241550) | Astellas Pharma Global Development, Inc. | 2017-10-02 |
| Biofeedback to Increase Propulsion During Walking After Stroke (NCT02667392) | VA Office of Research and Development | 2017-10-02 |
| To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer (NCT03215264) | Abramson Cancer Center at Penn Medicine | 2017-10-02 |
| Titration Study of ABX-1431 (NCT03447756) | Abide Therapeutics | 2017-10-02 |
| Phase I Study of BCD-145 (Anti-CTLA-4) in Patients With Unresectable/Metastatic Melanoma (NCT03472027) | Biocad | 2017-10-02 |
| Triamcinolone Levels in Cochlear Perilymph (NCT03248856) | Christoph Arnoldner | 2017-10-02 |
| Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers (NCT03302897) | Access to Advanced Health Institute (AAHI) | 2017-10-02 |
| Safety of Adipose-Derived Stem Cell Stromal Vascular Fraction (NCT02590042) | AdiSave Inc. | 2017-10-01 |
| REO13 Melanoma With of Without GM-CSF (NCT03282188) | University of Leeds | 2017-10-01 |
| Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma (NCT03281551) | Pinze Lifetechnology Co. Ltd. | 2017-10-01 |
| Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients (NCT03303144) | Rockwell Medical Technologies, Inc. | 2017-10-01 |
| A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions (NCT03512821) | Daewoong Pharmaceutical Co. LTD. | 2017-10-01 |
| Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma (NCT03283046) | M.D. Anderson Cancer Center | 2017-10-01 |
| Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2 (NCT03332355) | Vanquish Oncology, Inc. | 2017-10-01 |
| Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy (NCT03235167) | Dalian University | 2017-10-01 |
| ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy (NCT03145298) | Cedars-Sinai Medical Center | 2017-10-01 |
| Special Combination of OBP-301 and Pembrolizumab (NCT03172819) | Toshihiko Doi | 2017-10-01 |
| Effects of Marijuana on Symptoms of OCD (NCT03274440) | New York State Psychiatric Institute | 2017-10-01 |
| Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer. (NCT02602249) | Beijing Doing Biomedical Co., Ltd. | 2017-10-01 |
| Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers (NCT03259217) | Assiut University | 2017-10-01 |
| Effectiveness of Bioactiveglass Air Abrasion Versus Fluoride Varnish in Management of Dentin Hypersensitivity (NCT03285360) | Cairo University | 2017-10-01 |
| Study of PBF-999 in Solid Tumour Advanced Cancer (NCT03786484) | Palobiofarma SL | 2017-10-01 |
| Absorption and Excretion of Oral Docetaxel (NCT05242926) | Modra Pharmaceuticals | 2017-10-01 |
| ENB Robotic ICG Guided Surgery: A Novel Technique for Targeting Small Lung Tumors (NCT02570958) | St. Joseph's Healthcare Hamilton | 2017-10-01 |
| Human Amniotic Epithelial Cells for Asherman's Syndrome (NCT03223454) | The Second Affiliated Hospital of Chongqing Medical University | 2017-10-01 |
| Eucrisa for Atopic Dermatitis (NCT03250663) | Wake Forest University Health Sciences | 2017-10-01 |
| A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers (NCT03199690) | St. Stephens Clinical Research | 2017-10-01 |
| Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers (NCT02130661) | GlaxoSmithKline | 2017-10-01 |
| Mechanical Diagnosis and Treatment and/or Steroid Injections for Lumbar Radiculopathy (NCT02951377) | University of Alberta | 2017-10-01 |
| Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease (NCT03487263) | Implicit Bioscience | 2017-10-01 |
| Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women (NCT02875119) | Population Council | 2017-10-01 |
| ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ - 3-Dose Primary Series With Boost (NCT02386150) | U.S. Army Medical Research and Development Command | 2017-10-01 |
| Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo (NCT03358082) | Sohag University | 2017-10-01 |
| Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL (NCT02656147) | Beijing Doing Biomedical Co., Ltd. | 2017-10-01 |
| Vagal Stimulation in POTS (NCT03124355) | Vanderbilt University Medical Center | 2017-09-30 |
| Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support (NCT03091998) | Mayo Clinic | 2017-09-30 |
| Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia (NCT03007771) | Washington University School of Medicine | 2017-09-30 |
| Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients (NCT03325621) | Pieris Pharmaceuticals GmbH | 2017-09-30 |
| Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia (NCT04692285) | University Medical Centre Ljubljana | 2017-09-30 |
| Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19 (NCT02935257) | University College, London | 2017-09-29 |